Extended Data Fig. 3: ACE2 binding affinity of yeast display selected clones and designed variants.
From: SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution
* The affinity was determined by CF640-ACE2 titration (Fig. 2a) at 12-16 concentrations, binding to yeast expressing clones. Shading tones are according to library progression. The standard error values calculated from multiple measurements (number of repeats in brackets) are shown. Curve fitting errors did not exceed ± 10%.
